Kannurin, a novel lipopeptide from Bacillus cereus strain AK1: Isolation, structural evaluation and antifungal activities

Journal of Applied Microbiology

Volumn 115, Issue 6, 2013, Pages 1287-1296

  Ajesh, K ^a   Sudarslal, S ^b   Arunan, C ^c   Sreejith, K ^a  

^a KANNUR UNIVERSITY   (India)

^b AMRITA UNIVERSITY   (India)

^c MAHATMA GANDHI UNIVERSITY   (India)

Author keywords

Bacillus cereus; Biofilms; Cryptococcus neoformans; ESI MS; Lipopeptide; Melanin

Indexed keywords

ANTIBIOTICS; BACTERIOLOGY; BIOFILMS; ELECTRODEPOSITION; ELECTROSPRAY IONIZATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MOLDS; YEAST;

AMINO-ACIDS; ANTIFUNGAL ACTIVITIES; ANTIFUNGALS; CRYPTOCOCCUS NEOFORMANS; ELECTROSPRAY IONIZATION MASS SPECTRA; EVALUATION ACTIVITY; HEPTAPEPTIDES; LIPOPEPTIDES; STRUCTURAL EVALUATION; SURFACTINS;

BACILLUS CEREUS;

ANTIFUNGAL AGENT; KANNURIN; UNCLASSIFIED DRUG;

BIOFILM; FTIR SPECTROSCOPY; IONIZATION; MASS SPECTROMETRY; MELANIN; PEPTIDE; PH; STRAIN;

ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS CEREUS; CANDIDA; CONTROLLED STUDY; CRYPTOCOCCUS; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FUNGICIDAL ACTIVITY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; TEMPERATURE;

BACILLUS CEREUS; FILOBASIDIELLA NEOFORMANS;

EID: 84887828143     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12324     Document Type: Article

References (24)

1. Abriouel, H., Franz, C.M., Ben Omar, N. and Gálvez, A. (2011) Diversity and applications of Bacillus bacteriocins. FEMS Microbiol Rev 35, 201-232.
2. Ajesh, K. and Sreejith, K. (2009) Peptide antibiotics: an alternative and effective antimicrobial strategy to circumvent fungal infections. Peptides 30, 999-1006.
3. Antachopoulos, C. and Walsh, T.J. (2012) Immunotherapy of Cryptococcus infections. Clin Microbiol Infect 18, 126-133.
4. Biemann, K. (1990) Appendix 5. Nomenclature for peptide fragment ions (positive ions). Methods Enzymol 193, 886-887.
5. Bonmatin, J.M., Laprevote, O. and Peypoux, F. (2003) Diversity among microbial cyclic lipopeptides: iturins and surfactins. Activity-structure relationships to design new bioactive agents. Comb Chem High Throughput Screen 6, 541-556.
6. Clinical and Laboratory Standards Institute (2002a) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A2, 2nd edn. Wayne, USA: Clinical and Laboratory Standards Institute.
7. Clinical and Laboratory Standards Institute (2002b) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard M38-A2, 2nd edn. Wayne, USA: Clinical and Laboratory Standards Institute.
8. van Duin, D., Casadevall, A. and Nosanchuk, J.D. (2002) Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother 46, 3394-3400.
9. Grangemard, I., Bonmatin, J.M., Bernillon, J., Das, B.C. and Peypoux, F. (1999) Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry. J Antibiot (Tokyo) 52, 363-373.
10. Hancock, R.E.W. and Chapple, D.S. (1999) Peptide antibiotics. Antimicrob Agents Chemother 43, 1317-1323.
11. Kluge, B., Vater, J., Salnikow, J. and Eckart, K. (1998) Studies on the biosynthesis of surfactin, a lipopeptide antibiotic from Bacillus subtilis ATCC 21332. FEBS Lett 231, 107-110.
12. Lo, H.J., Kohler, J.R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A. and Fink, G.R. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939-949.
13. Logan, N.A. and Turnbull, P.C.B. (1995) Bacillus and recently derived genera. In Manual of Clinical Microbiology ed. Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C. and Yolken, R.H. pp. 357-369. Washington, DC: ASM Press.
14. Maget-Dana, R. and Peypoux, F. (1994) Iturins, a special class of pore forming lipopeptides: biological and physicochemical properties. Toxicology 87, 151-174.
15. Makovitzki, A., Avrahami, D. and Shai, Y. (2006) Ultrashort antibacterial and antifungal lipopeptides. PNAS 103, 15997-16002.
16. Marr, A.K., Gooderham, W.J. and Hancock, R.E. (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6, 468-472.
17. Ramage, G., Vande Walle, K., Wickes, B.L. and Lopez-Ribot, J.L. (2001) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45, 2475-2479.
18. Rosas, A.L., Nosanchuk, J.D., Gomez, B.L., Edens, W.A., Henson, J.M. and Casadevall, A. (2000) Isolation and serological analyses of fungal melanins. J Immunol Methods 244, 69-80.
19. Sabareesh, V., Ranganayaki, R.S., Raghothama, S., Bopanna, M.P., Balaram, H., Srinivasan, M.C. and Balaram, P. (2007) Identification and characterization of a library of microheterogeneous cyclohexadepsipeptides from the fungus Isaria. J Nat Prod 70, 715-729.
20. Sambrook, J. and Russel, D.W. (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. New York, NY: Cold Spring Harbour Laboratory Press.
21. Silveira, F.P. and Husain, S. (2007) Fungal infections in solid organ transplantation. Med Mycol 45, 305-320.
22. Tohidi, F., Toulami, S., Tolami, H.F., Tameshkel, F.S., Nourani, A., Seyedinasab, S.R., Nazemi, A. and Jafarpour, M. (2013) Isolation and molecular identification of cry gene in Bacillus thuringiensis isolated from soils by semi-conserve PCR. Eur J Exp Biol 3, 452-456.
23. Vanittanakom, N., Loeffler, W., Koch, U. and Jung, G. (1986) Fengycin-a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot (Tokyo) 39, 888-901.
24. Wakayama, S., Ishikawa, F. and Oishi, K. (1984) Mycocerein, a novel antifungal peptide antibiotic produced by Bacillus cereus. Antimicrob Agents Chemother 26, 939-940.